Medacta International is a world leading manufacturer of orthopaedic implants, neurosurgical systems, and instrumentation. Medacta’s revolutionary approach and responsible innovation have resulted in standard of care breakthroughs in hip replacement with the AMIS system and total knee r eplacement with MyKnee patient matched technology. Over the last 10 years, Medacta has grown dramatically by taking a holistic approach and placing value on all aspects of the care experience from design to training to sustainability. Medacta is headquartered in Castel San Pietro, Switzerland, and operates in 30 countries.
“Medacta is unique in its focus on surgeon education and training, and its approach to collaborating with the surgical community to improve the art, science, and outcomes of orthopaedic procedures,” said Dr. Frédéric Laude, a pioneer in the anterior approach for hip replacement.
